Cargando…
Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway
The effects of epigallocatechingallate (EGCG) on the migration and expression of MMP-2 of uveal melanoma cells have not been reported. We studied this effect and relevant signaling pathways in a human uveal melanoma cell line (M17). MTT study found that EGCG did not affect the cell viability of M17...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145379/ https://www.ncbi.nlm.nih.gov/pubmed/25184134 http://dx.doi.org/10.1155/2014/141582 |
_version_ | 1782332165718016000 |
---|---|
author | Chang, Chi-Wu Hsieh, Yi-Hsien Yang, Wei-En Yang, Shun-Fa Chen, Yueqin Hu, Dan-Ning |
author_facet | Chang, Chi-Wu Hsieh, Yi-Hsien Yang, Wei-En Yang, Shun-Fa Chen, Yueqin Hu, Dan-Ning |
author_sort | Chang, Chi-Wu |
collection | PubMed |
description | The effects of epigallocatechingallate (EGCG) on the migration and expression of MMP-2 of uveal melanoma cells have not been reported. We studied this effect and relevant signaling pathways in a human uveal melanoma cell line (M17). MTT study found that EGCG did not affect the cell viability of M17 cells up to 100 µM. Wound-healing assay showed that EGCG significantly reduced the migration of melanoma cells in a dose-dependent manner from 20 to 100 µM. Gelatin zymography showed that secreted MMP-2 activity was dose-dependently inhibited by EGCG, whereas the MMP-2 expression at protein and mRNA levels was not affected as determined by western blot and RT-PCR analysis. EGCG significantly increased the expressions of MMP-2 endogenous inhibitors (TIMP-2 and RECK) in M17 cells. Western blot analysis of MAPK signal pathways showed that EGCG significantly decreased phosphorylated ERK1/2 levels, but not p38 and JNK levels, in melanoma cells. ERK1/2 inhibitors also reduced the migration and activity of MMP-2 in M17 cells. The present study suggested EGCG at nontoxic levels could inhibit migration of melanoma cells via downregulation of activities of secreted MMP-2 through the inhibition of the ERK1/2 phosphorylation. Therefore, EGCG may be a promising agent to be explored for the prevention of metastasis of uveal melanoma. |
format | Online Article Text |
id | pubmed-4145379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-41453792014-09-02 Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway Chang, Chi-Wu Hsieh, Yi-Hsien Yang, Wei-En Yang, Shun-Fa Chen, Yueqin Hu, Dan-Ning Biomed Res Int Research Article The effects of epigallocatechingallate (EGCG) on the migration and expression of MMP-2 of uveal melanoma cells have not been reported. We studied this effect and relevant signaling pathways in a human uveal melanoma cell line (M17). MTT study found that EGCG did not affect the cell viability of M17 cells up to 100 µM. Wound-healing assay showed that EGCG significantly reduced the migration of melanoma cells in a dose-dependent manner from 20 to 100 µM. Gelatin zymography showed that secreted MMP-2 activity was dose-dependently inhibited by EGCG, whereas the MMP-2 expression at protein and mRNA levels was not affected as determined by western blot and RT-PCR analysis. EGCG significantly increased the expressions of MMP-2 endogenous inhibitors (TIMP-2 and RECK) in M17 cells. Western blot analysis of MAPK signal pathways showed that EGCG significantly decreased phosphorylated ERK1/2 levels, but not p38 and JNK levels, in melanoma cells. ERK1/2 inhibitors also reduced the migration and activity of MMP-2 in M17 cells. The present study suggested EGCG at nontoxic levels could inhibit migration of melanoma cells via downregulation of activities of secreted MMP-2 through the inhibition of the ERK1/2 phosphorylation. Therefore, EGCG may be a promising agent to be explored for the prevention of metastasis of uveal melanoma. Hindawi Publishing Corporation 2014 2014-08-12 /pmc/articles/PMC4145379/ /pubmed/25184134 http://dx.doi.org/10.1155/2014/141582 Text en Copyright © 2014 Chi-Wu Chang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Chang, Chi-Wu Hsieh, Yi-Hsien Yang, Wei-En Yang, Shun-Fa Chen, Yueqin Hu, Dan-Ning Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway |
title | Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway |
title_full | Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway |
title_fullStr | Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway |
title_full_unstemmed | Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway |
title_short | Epigallocatechingallate Inhibits Migration of Human Uveal Melanoma Cells via Downregulation of Matrix Metalloproteinase-2 Activity and ERK1/2 Pathway |
title_sort | epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and erk1/2 pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145379/ https://www.ncbi.nlm.nih.gov/pubmed/25184134 http://dx.doi.org/10.1155/2014/141582 |
work_keys_str_mv | AT changchiwu epigallocatechingallateinhibitsmigrationofhumanuvealmelanomacellsviadownregulationofmatrixmetalloproteinase2activityanderk12pathway AT hsiehyihsien epigallocatechingallateinhibitsmigrationofhumanuvealmelanomacellsviadownregulationofmatrixmetalloproteinase2activityanderk12pathway AT yangweien epigallocatechingallateinhibitsmigrationofhumanuvealmelanomacellsviadownregulationofmatrixmetalloproteinase2activityanderk12pathway AT yangshunfa epigallocatechingallateinhibitsmigrationofhumanuvealmelanomacellsviadownregulationofmatrixmetalloproteinase2activityanderk12pathway AT chenyueqin epigallocatechingallateinhibitsmigrationofhumanuvealmelanomacellsviadownregulationofmatrixmetalloproteinase2activityanderk12pathway AT hudanning epigallocatechingallateinhibitsmigrationofhumanuvealmelanomacellsviadownregulationofmatrixmetalloproteinase2activityanderk12pathway |